Global Cefotaxime Sodium API Market Growth 2020-2025
According to this study, over the next five years the Cefotaxime Sodium API market will register a -0.8%% CAGR in terms of revenue, the global market size will reach $ 96.7 million by 2025, from $ 100 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cefotaxime Sodium API business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Cefotaxime Sodium API market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Cefotaxime Sodium API, covering the supply chain analysis, impact assessment to the Cefotaxime Sodium API market size growth rate in several scenarios, and the measures to be undertaken by Cefotaxime Sodium API companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
ChP
USP
EP
Chp refers to Chinese Pharmacopoeia. USP refers to the United States Pharmacopeia. EP refers to the European Pharmacopoeia. And the proportion of ChP in 2019 is about 77.92%.
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Single Injection
Compound Injection
Cefotaxime sodium API is widely for single injection and compound injection. The proportion of single injection in 2019 is about 76.02%.
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
REYOUNG
CSPC
Nectar Lifesciences
Sandoz
Kelun
Medya Pharma
United Laboratories
NCPC
Orchid Pharma
Aurobindo Pharma
Kopran
Dawnrays
ACS Dobfar
Sterile India
Covalent
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Cefotaxime Sodium API consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Cefotaxime Sodium API market by identifying its various subsegments.
Focuses on the key global Cefotaxime Sodium API manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cefotaxime Sodium API with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Cefotaxime Sodium API submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cefotaxime Sodium API Consumption 2015-2025
2.1.2 Cefotaxime Sodium API Consumption CAGR by Region
2.2 Cefotaxime Sodium API Segment by Type
2.2.1 ChP
2.2.2 USP
2.2.3 EP
2.3 Cefotaxime Sodium API Consumption by Type
2.3.1 Global Cefotaxime Sodium API Consumption Market Share by Type (2015-2020)
2.3.2 Global Cefotaxime Sodium API Revenue and Market Share by Type (2015-2020)
2.3.3 Global Cefotaxime Sodium API Sale Price by Type (2015-2020)
2.4 Cefotaxime Sodium API Segment by Application
2.4.1 Single Injection
2.4.2 Compound Injection
2.5 Cefotaxime Sodium API Consumption by Application
2.5.1 Global Cefotaxime Sodium API Consumption Market Share by Type (2015-2020)
2.5.2 Global Cefotaxime Sodium API Value and Market Share by Type (2015-2020)
2.5.3 Global Cefotaxime Sodium API Sale Price by Type (2015-2020)
3 Global Cefotaxime Sodium API by Company
3.1 Global Cefotaxime Sodium API Sales Market Share by Company
3.1.1 Global Cefotaxime Sodium API Sales by Company (2018-2020)
3.1.2 Global Cefotaxime Sodium API Sales Market Share by Company (2018-2020)
3.2 Global Cefotaxime Sodium API Revenue Market Share by Company
3.2.1 Global Cefotaxime Sodium API Revenue by Company (2018-2020)
3.2.2 Global Cefotaxime Sodium API Revenue Market Share by Company (2018-2020)
3.3 Global Cefotaxime Sodium API Sale Price by Company
3.4 Global Cefotaxime Sodium API Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Cefotaxime Sodium API Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Cefotaxime Sodium API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Cefotaxime Sodium API by Regions
4.1 Cefotaxime Sodium API by Regions
4.2 Americas Cefotaxime Sodium API Consumption Growth
4.3 APAC Cefotaxime Sodium API Consumption Growth
4.4 Europe Cefotaxime Sodium API Consumption Growth
4.5 Middle East & Africa Cefotaxime Sodium API Consumption Growth
5 Americas
5.1 Americas Cefotaxime Sodium API Consumption by Countries
5.1.1 Americas Cefotaxime Sodium API Consumption by Countries (2015-2020)
5.1.2 Americas Cefotaxime Sodium API Value by Countries (2015-2020)
5.2 Americas Cefotaxime Sodium API Consumption by Type
5.3 Americas Cefotaxime Sodium API Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Cefotaxime Sodium API Consumption by Regions
6.1.1 APAC Cefotaxime Sodium API Consumption by Regions (2015-2020)
6.1.2 APAC Cefotaxime Sodium API Value by Regions (2015-2020)
6.2 APAC Cefotaxime Sodium API Consumption by Type
6.3 APAC Cefotaxime Sodium API Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Cefotaxime Sodium API by Countries
7.1.1 Europe Cefotaxime Sodium API Consumption by Countries (2015-2020)
7.1.2 Europe Cefotaxime Sodium API Value by Countries (2015-2020)
7.2 Europe Cefotaxime Sodium API Consumption by Type
7.3 Europe Cefotaxime Sodium API Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Cefotaxime Sodium API by Countries
8.1.1 Middle East & Africa Cefotaxime Sodium API Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Cefotaxime Sodium API Value by Countries (2015-2020)
8.2 Middle East & Africa Cefotaxime Sodium API Consumption by Type
8.3 Middle East & Africa Cefotaxime Sodium API Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Cefotaxime Sodium API Distributors
10.3 Cefotaxime Sodium API Customer
11 Global Cefotaxime Sodium API Market Forecast
11.1 Global Cefotaxime Sodium API Consumption Forecast (2021-2025)
11.2 Global Cefotaxime Sodium API Forecast by Regions
11.2.1 Global Cefotaxime Sodium API Forecast by Regions (2021-2025)
11.2.2 Global Cefotaxime Sodium API Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Cefotaxime Sodium API Forecast by Type
11.8 Global Cefotaxime Sodium API Forecast by Application
12 Key Players Analysis
12.1 REYOUNG
12.1.1 Company Information
12.1.2 Cefotaxime Sodium API Product Offered
12.1.3 REYOUNG Cefotaxime Sodium API Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 REYOUNG Latest Developments
12.2 CSPC
12.2.1 Company Information
12.2.2 Cefotaxime Sodium API Product Offered
12.2.3 CSPC Cefotaxime Sodium API Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 CSPC Latest Developments
12.3 Nectar Lifesciences
12.3.1 Company Information
12.3.2 Cefotaxime Sodium API Product Offered
12.3.3 Nectar Lifesciences Cefotaxime Sodium API Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Nectar Lifesciences Latest Developments
12.4 Sandoz
12.4.1 Company Information
12.4.2 Cefotaxime Sodium API Product Offered
12.4.3 Sandoz Cefotaxime Sodium API Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Sandoz Latest Developments
12.5 Kelun
12.5.1 Company Information
12.5.2 Cefotaxime Sodium API Product Offered
12.5.3 Kelun Cefotaxime Sodium API Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Kelun Latest Developments
12.6 Medya Pharma
12.6.1 Company Information
12.6.2 Cefotaxime Sodium API Product Offered
12.6.3 Medya Pharma Cefotaxime Sodium API Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Medya Pharma Latest Developments
12.7 United Laboratories
12.7.1 Company Information
12.7.2 Cefotaxime Sodium API Product Offered
12.7.3 United Laboratories Cefotaxime Sodium API Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 United Laboratories Latest Developments
12.8 NCPC
12.8.1 Company Information
12.8.2 Cefotaxime Sodium API Product Offered
12.8.3 NCPC Cefotaxime Sodium API Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 NCPC Latest Developments
12.9 Orchid Pharma
12.9.1 Company Information
12.9.2 Cefotaxime Sodium API Product Offered
12.9.3 Orchid Pharma Cefotaxime Sodium API Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Orchid Pharma Latest Developments
12.10 Aurobindo Pharma
12.10.1 Company Information
12.10.2 Cefotaxime Sodium API Product Offered
12.10.3 Aurobindo Pharma Cefotaxime Sodium API Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Aurobindo Pharma Latest Developments
12.11 Kopran
12.11.1 Company Information
12.11.2 Cefotaxime Sodium API Product Offered
12.11.3 Kopran Cefotaxime Sodium API Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Kopran Latest Developments
12.12 Dawnrays
12.12.1 Company Information
12.12.2 Cefotaxime Sodium API Product Offered
12.12.3 Dawnrays Cefotaxime Sodium API Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Dawnrays Latest Developments
12.13 ACS Dobfar
12.13.1 Company Information
12.13.2 Cefotaxime Sodium API Product Offered
12.13.3 ACS Dobfar Cefotaxime Sodium API Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 ACS Dobfar Latest Developments
12.14 Sterile India
12.14.1 Company Information
12.14.2 Cefotaxime Sodium API Product Offered
12.14.3 Sterile India Cefotaxime Sodium API Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Sterile India Latest Developments
12.15 Covalent
12.15.1 Company Information
12.15.2 Cefotaxime Sodium API Product Offered
12.15.3 Covalent Cefotaxime Sodium API Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Covalent Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Cefotaxime Sodium API Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of ChP
Table 5. Major Players of USP
Table 6. Major Players of EP
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Cefotaxime Sodium API Consumption Market Share by Type (2015-2020)
Table 9. Global Cefotaxime Sodium API Revenue by Type (2015-2020) ($ million)
Table 10. Global Cefotaxime Sodium API Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Cefotaxime Sodium API Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Cefotaxime Sodium API Consumption Market Share by Application (2015-2020)
Table 14. Global Cefotaxime Sodium API Value by Application (2015-2020)
Table 15. Global Cefotaxime Sodium API Value Market Share by Application (2015-2020)
Table 16. Global Cefotaxime Sodium API Sale Price by Application (2015-2020)
Table 17. Global Cefotaxime Sodium API Sales by Company (2017-2019) (MT)
Table 18. Global Cefotaxime Sodium API Sales Market Share by Company (2017-2019)
Table 19. Global Cefotaxime Sodium API Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Cefotaxime Sodium API Revenue Market Share by Company (2017-2019)
Table 21. Global Cefotaxime Sodium API Sale Price by Company (2017-2019)
Table 22. Global Cefotaxime Sodium API Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Cefotaxime Sodium API Products Offered
Table 24. Cefotaxime Sodium API Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Cefotaxime Sodium API Consumption by Regions 2015-2020 (MT)
Table 26. Global Cefotaxime Sodium API Consumption Market Share by Regions 2015-2020
Table 27. Global Cefotaxime Sodium API Value by Regions 2015-2020 ($ Millions)
Table 28. Global Cefotaxime Sodium API Value Market Share by Regions 2015-2020
Table 29. Americas Cefotaxime Sodium API Consumption by Countries (2015-2020) (MT)
Table 30. Americas Cefotaxime Sodium API Consumption Market Share by Countries (2015-2020)
Table 31. Americas Cefotaxime Sodium API Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Cefotaxime Sodium API Value Market Share by Countries (2015-2020)
Table 33. Americas Cefotaxime Sodium API Consumption by Type (2015-2020) (MT)
Table 34. Americas Cefotaxime Sodium API Consumption Market Share by Type (2015-2020)
Table 35. Americas Cefotaxime Sodium API Consumption by Application (2015-2020) (MT)
Table 36. Americas Cefotaxime Sodium API Consumption Market Share by Application (2015-2020)
Table 37. APAC Cefotaxime Sodium API Consumption by Countries (2015-2020) (MT)
Table 38. APAC Cefotaxime Sodium API Consumption Market Share by Countries (2015-2020)
Table 39. APAC Cefotaxime Sodium API Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Cefotaxime Sodium API Value Market Share by Regions (2015-2020)
Table 41. APAC Cefotaxime Sodium API Consumption by Type (2015-2020) (MT)
Table 42. APAC Cefotaxime Sodium API Consumption Market Share by Type (2015-2020)
Table 43. APAC Cefotaxime Sodium API Consumption by Application (2015-2020) (MT)
Table 44. APAC Cefotaxime Sodium API Consumption Market Share by Application (2015-2020)
Table 45. Europe Cefotaxime Sodium API Consumption by Countries (2015-2020) (MT)
Table 46. Europe Cefotaxime Sodium API Consumption Market Share by Countries (2015-2020)
Table 47. Europe Cefotaxime Sodium API Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Cefotaxime Sodium API Value Market Share by Countries (2015-2020)
Table 49. Europe Cefotaxime Sodium API Consumption by Type (2015-2020) (MT)
Table 50. Europe Cefotaxime Sodium API Consumption Market Share by Type (2015-2020)
Table 51. Europe Cefotaxime Sodium API Consumption by Application (2015-2020) (MT)
Table 52. Europe Cefotaxime Sodium API Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Cefotaxime Sodium API Consumption by Countries (2015-2020) (MT)
Table 54. Middle East & Africa Cefotaxime Sodium API Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Cefotaxime Sodium API Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Cefotaxime Sodium API Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Cefotaxime Sodium API Consumption by Type (2015-2020) (MT)
Table 58. Middle East & Africa Cefotaxime Sodium API Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Cefotaxime Sodium API Consumption by Application (2015-2020) (MT)
Table 60. Middle East & Africa Cefotaxime Sodium API Consumption Market Share by Application (2015-2020)
Table 61. Cefotaxime Sodium API Distributors List
Table 62. Cefotaxime Sodium API Customer List
Table 63. Global Cefotaxime Sodium API Consumption Forecast by Countries (2021-2025) (MT)
Table 64. Global Cefotaxime Sodium API Consumption Market Forecast by Regions
Table 65. Global Cefotaxime Sodium API Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Cefotaxime Sodium API Value Market Share Forecast by Regions
Table 67. Global Cefotaxime Sodium API Consumption Forecast by Type (2021-2025) (MT)
Table 68. Global Cefotaxime Sodium API Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Cefotaxime Sodium API Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Cefotaxime Sodium API Value Market Share Forecast by Type (2021-2025)
Table 71. Global Cefotaxime Sodium API Consumption Forecast by Application (2021-2025) (MT)
Table 72. Global Cefotaxime Sodium API Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Cefotaxime Sodium API Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Cefotaxime Sodium API Value Market Share Forecast by Application (2021-2025)
Table 75. REYOUNG Product Offered
Table 76. REYOUNG Cefotaxime Sodium API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 77. REYOUNG Main Business
Table 78. REYOUNG Latest Developments
Table 79. REYOUNG Basic Information, Company Total Revenue (in $ million), Cefotaxime Sodium API Manufacturing Base, Sales Area and Its Competitors
Table 80. CSPC Product Offered
Table 81. CSPC Cefotaxime Sodium API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 82. CSPC Main Business
Table 83. CSPC Latest Developments
Table 84. CSPC Basic Information, Company Total Revenue (in $ million), Cefotaxime Sodium API Manufacturing Base, Sales Area and Its Competitors
Table 85. Nectar Lifesciences Product Offered
Table 86. Nectar Lifesciences Cefotaxime Sodium API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 87. Nectar Lifesciences Main Business
Table 88. Nectar Lifesciences Latest Developments
Table 89. Nectar Lifesciences Basic Information, Company Total Revenue (in $ million), Cefotaxime Sodium API Manufacturing Base, Sales Area and Its Competitors
Table 90. Sandoz Product Offered
Table 91. Sandoz Cefotaxime Sodium API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 92. Sandoz Main Business
Table 93. Sandoz Latest Developments
Table 94. Sandoz Basic Information, Company Total Revenue (in $ million), Cefotaxime Sodium API Manufacturing Base, Sales Area and Its Competitors
Table 95. Kelun Product Offered
Table 96. Kelun Cefotaxime Sodium API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 97. Kelun Main Business
Table 98. Kelun Latest Developments
Table 99. Kelun Basic Information, Company Total Revenue (in $ million), Cefotaxime Sodium API Manufacturing Base, Sales Area and Its Competitors
Table 100. Medya Pharma Product Offered
Table 101. Medya Pharma Cefotaxime Sodium API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 102. Medya Pharma Main Business
Table 103. Medya Pharma Latest Developments
Table 104. Medya Pharma Basic Information, Company Total Revenue (in $ million), Cefotaxime Sodium API Manufacturing Base, Sales Area and Its Competitors
Table 105. United Laboratories Product Offered
Table 106. United Laboratories Basic Information, Company Total Revenue (in $ million), Cefotaxime Sodium API Manufacturing Base, Sales Area and Its Competitors
Table 107. United Laboratories Main Business
Table 108. United Laboratories Latest Developments
Table 109. United Laboratories Cefotaxime Sodium API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 110. NCPC Product Offered
Table 111. NCPC Cefotaxime Sodium API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 112. NCPC Main Business
Table 113. NCPC Latest Developments
Table 114. NCPC Basic Information, Company Total Revenue (in $ million), Cefotaxime Sodium API Manufacturing Base, Sales Area and Its Competitors
Table 115. Orchid Pharma Product Offered
Table 116. Orchid Pharma Cefotaxime Sodium API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 117. Orchid Pharma Main Business
Table 118. Orchid Pharma Latest Developments
Table 119. Orchid Pharma Basic Information, Company Total Revenue (in $ million), Cefotaxime Sodium API Manufacturing Base, Sales Area and Its Competitors
Table 120. Aurobindo Pharma Product Offered
Table 121. Aurobindo Pharma Cefotaxime Sodium API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 122. Aurobindo Pharma Main Business
Table 123. Aurobindo Pharma Latest Developments
Table 124. Aurobindo Pharma Basic Information, Company Total Revenue (in $ million), Cefotaxime Sodium API Manufacturing Base, Sales Area and Its Competitors
Table 125. Kopran Product Offered
Table 126. Kopran Cefotaxime Sodium API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 127. Kopran Main Business
Table 128. Kopran Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. Kopran Latest Developments
Table 130. Dawnrays Product Offered
Table 131. Dawnrays Cefotaxime Sodium API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 132. Dawnrays Main Business
Table 133. Dawnrays Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 134. Dawnrays Latest Developments
Table 135. ACS Dobfar Product Offered
Table 136. ACS Dobfar Cefotaxime Sodium API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 137. ACS Dobfar Main Business
Table 138. ACS Dobfar Latest Developments
Table 139. ACS Dobfar Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 140. Sterile India Product Offered
Table 141. Sterile India Cefotaxime Sodium API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 142. Sterile India Main Business
Table 143. Sterile India Latest Developments
Table 144. Sterile India Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 145. Covalent Product Offered
Table 146. Covalent Cefotaxime Sodium API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 147. Covalent Main Business
Table 148. Covalent Latest Developments
Table 149. Covalent Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Cefotaxime Sodium API
Figure 2. Cefotaxime Sodium API Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Cefotaxime Sodium API Consumption Growth Rate 2015-2025 (MT)
Figure 5. Global Cefotaxime Sodium API Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of ChP
Figure 7. Product Picture of USP
Figure 8. Product Picture of EP
Figure 9. Global Cefotaxime Sodium API Consumption Market Share by Type (2015-2020)
Figure 10. Global Cefotaxime Sodium API Value Market Share by Type (2015-2020)
Figure 11. Cefotaxime Sodium API Consumed in Single Injection
Figure 12. Global Cefotaxime Sodium API Market: Single Injection (2015-2020) (MT)
Figure 13. Global Cefotaxime Sodium API Market: Single Injection (2015-2020) ($ Millions)
Figure 14. Cefotaxime Sodium API Consumed in Compound Injection
Figure 15. Global Cefotaxime Sodium API Market: Compound Injection (2015-2020) (MT)
Figure 16. Global Cefotaxime Sodium API Market: Compound Injection (2015-2020) ($ Millions)
Figure 17. Global Cefotaxime Sodium API Consumption Market Share by Application (2015-2020)
Figure 18. Global Cefotaxime Sodium API Value Market Share by Application (2015-2020)
Figure 19. Global Cefotaxime Sodium API Sales Market Share by Company in 2017
Figure 20. Global Cefotaxime Sodium API Sales Market Share by Company in 2019
Figure 21. Global Cefotaxime Sodium API Revenue Market Share by Company in 2017
Figure 22. Global Cefotaxime Sodium API Revenue Market Share by Company in 2019
Figure 23. Global Cefotaxime Sodium API Sale Price by Company in 2019
Figure 24. Global Cefotaxime Sodium API Consumption Market Share by Regions 2015-2020
Figure 25. Global Cefotaxime Sodium API Value Market Share by Regions 2015-2020
Figure 26. Americas Cefotaxime Sodium API Consumption 2015-2020 (MT)
Figure 27. Americas Cefotaxime Sodium API Value 2015-2020 ($ Millions)
Figure 28. APAC Cefotaxime Sodium API Consumption 2015-2020 (MT)
Figure 29. APAC Cefotaxime Sodium API Value 2015-2020 ($ Millions)
Figure 30. Europe Cefotaxime Sodium API Consumption 2015-2020 (MT)
Figure 31. Europe Cefotaxime Sodium API Value 2015-2020 ($ Millions)
Figure 32. Middle East & Africa Cefotaxime Sodium API Consumption 2015-2020 (MT)
Figure 33. Middle East & Africa Cefotaxime Sodium API Value 2015-2020 ($ Millions)
Figure 34. Americas Cefotaxime Sodium API Consumption Market Share by Countries in 2019
Figure 35. Americas Cefotaxime Sodium API Value Market Share by Countries in 2019
Figure 36. Americas Cefotaxime Sodium API Consumption Market Share by Type in 2019
Figure 37. Americas Cefotaxime Sodium API Consumption Market Share by Application in 2019
Figure 38. United States Cefotaxime Sodium API Consumption Growth 2015-2020 (MT)
Figure 39. United States Cefotaxime Sodium API Value Growth 2015-2020 ($ Millions)
Figure 40. Canada Cefotaxime Sodium API Consumption Growth 2015-2020 (MT)
Figure 41. Canada Cefotaxime Sodium API Value Growth 2015-2020 ($ Millions)
Figure 42. Mexico Cefotaxime Sodium API Consumption Growth 2015-2020 (MT)
Figure 43. Mexico Cefotaxime Sodium API Value Growth 2015-2020 ($ Millions)
Figure 44. APAC Cefotaxime Sodium API Consumption Market Share by Countries in 2019
Figure 45. APAC Cefotaxime Sodium API Value Market Share by Regions in 2019
Figure 46. APAC Cefotaxime Sodium API Consumption Market Share by Type in 2019
Figure 47. APAC Cefotaxime Sodium API Consumption Market Share by Application in 2019
Figure 48. China Cefotaxime Sodium API Consumption Growth 2015-2020 (MT)
Figure 49. China Cefotaxime Sodium API Value Growth 2015-2020 ($ Millions)
Figure 50. Japan Cefotaxime Sodium API Consumption Growth 2015-2020 (MT)
Figure 51. Japan Cefotaxime Sodium API Value Growth 2015-2020 ($ Millions)
Figure 52. Korea Cefotaxime Sodium API Consumption Growth 2015-2020 (MT)
Figure 53. Korea Cefotaxime Sodium API Value Growth 2015-2020 ($ Millions)
Figure 54. Southeast Asia Cefotaxime Sodium API Consumption Growth 2015-2020 (MT)
Figure 55. Southeast Asia Cefotaxime Sodium API Value Growth 2015-2020 ($ Millions)
Figure 56. India Cefotaxime Sodium API Consumption Growth 2015-2020 (MT)
Figure 57. India Cefotaxime Sodium API Value Growth 2015-2020 ($ Millions)
Figure 58. Australia Cefotaxime Sodium API Consumption Growth 2015-2020 (MT)
Figure 59. Australia Cefotaxime Sodium API Value Growth 2015-2020 ($ Millions)
Figure 60. Europe Cefotaxime Sodium API Consumption Market Share by Countries in 2019
Figure 61. Europe Cefotaxime Sodium API Value Market Share by Countries in 2019
Figure 62. Europe Cefotaxime Sodium API Consumption Market Share by Type in 2019
Figure 63. Europe Cefotaxime Sodium API Consumption Market Share by Application in 2019
Figure 64. Germany Cefotaxime Sodium API Consumption Growth 2015-2020 (MT)
Figure 65. Germany Cefotaxime Sodium API Value Growth 2015-2020 ($ Millions)
Figure 66. France Cefotaxime Sodium API Consumption Growth 2015-2020 (MT)
Figure 67. France Cefotaxime Sodium API Value Growth 2015-2020 ($ Millions)
Figure 68. UK Cefotaxime Sodium API Consumption Growth 2015-2020 (MT)
Figure 69. UK Cefotaxime Sodium API Value Growth 2015-2020 ($ Millions)
Figure 70. Italy Cefotaxime Sodium API Consumption Growth 2015-2020 (MT)
Figure 71. Italy Cefotaxime Sodium API Value Growth 2015-2020 ($ Millions)
Figure 72. Russia Cefotaxime Sodium API Consumption Growth 2015-2020 (MT)
Figure 73. Russia Cefotaxime Sodium API Value Growth 2015-2020 ($ Millions)
Figure 74. Middle East & Africa Cefotaxime Sodium API Consumption Market Share by Countries in 2019
Figure 75. Middle East & Africa Cefotaxime Sodium API Value Market Share by Countries in 2019
Figure 76. Middle East & Africa Cefotaxime Sodium API Consumption Market Share by Type in 2019
Figure 77. Middle East & Africa Cefotaxime Sodium API Consumption Market Share by Application in 2019
Figure 78. Egypt Cefotaxime Sodium API Consumption Growth 2015-2020 (MT)
Figure 79. Egypt Cefotaxime Sodium API Value Growth 2015-2020 ($ Millions)
Figure 80. South Africa Cefotaxime Sodium API Consumption Growth 2015-2020 (MT)
Figure 81. South Africa Cefotaxime Sodium API Value Growth 2015-2020 ($ Millions)
Figure 82. Israel Cefotaxime Sodium API Consumption Growth 2015-2020 (MT)
Figure 83. Israel Cefotaxime Sodium API Value Growth 2015-2020 ($ Millions)
Figure 84. Turkey Cefotaxime Sodium API Consumption Growth 2015-2020 (MT)
Figure 85. Turkey Cefotaxime Sodium API Value Growth 2015-2020 ($ Millions)
Figure 86. GCC Countries Cefotaxime Sodium API Consumption Growth 2015-2020 (MT)
Figure 87. GCC Countries Cefotaxime Sodium API Value Growth 2015-2020 ($ Millions)
Figure 88. Global Cefotaxime Sodium API Consumption Growth Rate Forecast (2021-2025) (MT)
Figure 89. Global Cefotaxime Sodium API Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 90. Americas Cefotaxime Sodium API Consumption 2021-2025 (MT)
Figure 91. Americas Cefotaxime Sodium API Value 2021-2025 ($ Millions)
Figure 92. APAC Cefotaxime Sodium API Consumption 2021-2025 (MT)
Figure 93. APAC Cefotaxime Sodium API Value 2021-2025 ($ Millions)
Figure 94. Europe Cefotaxime Sodium API Consumption 2021-2025 (MT)
Figure 95. Europe Cefotaxime Sodium API Value 2021-2025 ($ Millions)
Figure 96. Middle East & Africa Cefotaxime Sodium API Consumption 2021-2025 (MT)
Figure 97. Middle East & Africa Cefotaxime Sodium API Value 2021-2025 ($ Millions)
Figure 98. United States Cefotaxime Sodium API Consumption 2021-2025 (MT)
Figure 99. United States Cefotaxime Sodium API Value 2021-2025 ($ Millions)
Figure 100. Canada Cefotaxime Sodium API Consumption 2021-2025 (MT)
Figure 101. Canada Cefotaxime Sodium API Value 2021-2025 ($ Millions)
Figure 102. Mexico Cefotaxime Sodium API Consumption 2021-2025 (MT)
Figure 103. Mexico Cefotaxime Sodium API Value 2021-2025 ($ Millions)
Figure 104. Brazil Cefotaxime Sodium API Consumption 2021-2025 (MT)
Figure 105. Brazil Cefotaxime Sodium API Value 2021-2025 ($ Millions)
Figure 106. China Cefotaxime Sodium API Consumption 2021-2025 (MT)
Figure 107. China Cefotaxime Sodium API Value 2021-2025 ($ Millions)
Figure 108. Japan Cefotaxime Sodium API Consumption 2021-2025 (MT)
Figure 109. Japan Cefotaxime Sodium API Value 2021-2025 ($ Millions)
Figure 110. Korea Cefotaxime Sodium API Consumption 2021-2025 (MT)
Figure 111. Korea Cefotaxime Sodium API Value 2021-2025 ($ Millions)
Figure 112. Southeast Asia Cefotaxime Sodium API Consumption 2021-2025 (MT)
Figure 113. Southeast Asia Cefotaxime Sodium API Value 2021-2025 ($ Millions)
Figure 114. India Cefotaxime Sodium API Consumption 2021-2025 (MT)
Figure 115. India Cefotaxime Sodium API Value 2021-2025 ($ Millions)
Figure 116. Australia Cefotaxime Sodium API Consumption 2021-2025 (MT)
Figure 117. Australia Cefotaxime Sodium API Value 2021-2025 ($ Millions)
Figure 118. Germany Cefotaxime Sodium API Consumption 2021-2025 (MT)
Figure 119. Germany Cefotaxime Sodium API Value 2021-2025 ($ Millions)
Figure 120. France Cefotaxime Sodium API Consumption 2021-2025 (MT)
Figure 121. France Cefotaxime Sodium API Value 2021-2025 ($ Millions)
Figure 122. UK Cefotaxime Sodium API Consumption 2021-2025 (MT)
Figure 123. UK Cefotaxime Sodium API Value 2021-2025 ($ Millions)
Figure 124. Italy Cefotaxime Sodium API Consumption 2021-2025 (MT)
Figure 125. Italy Cefotaxime Sodium API Value 2021-2025 ($ Millions)
Figure 126. Russia Cefotaxime Sodium API Consumption 2021-2025 (MT)
Figure 127. Russia Cefotaxime Sodium API Value 2021-2025 ($ Millions)
Figure 128. Spain Cefotaxime Sodium API Consumption 2021-2025 (MT)
Figure 129. Spain Cefotaxime Sodium API Value 2021-2025 ($ Millions)
Figure 130. Egypt Cefotaxime Sodium API Consumption 2021-2025 (MT)
Figure 131. Egypt Cefotaxime Sodium API Value 2021-2025 ($ Millions)
Figure 132. South Africa Cefotaxime Sodium API Consumption 2021-2025 (MT)
Figure 133. South Africa Cefotaxime Sodium API Value 2021-2025 ($ Millions)
Figure 134. Israel Cefotaxime Sodium API Consumption 2021-2025 (MT)
Figure 135. Israel Cefotaxime Sodium API Value 2021-2025 ($ Millions)
Figure 136. Turkey Cefotaxime Sodium API Consumption 2021-2025 (MT)
Figure 137. Turkey Cefotaxime Sodium API Value 2021-2025 ($ Millions)
Figure 138. GCC Countries Cefotaxime Sodium API Consumption 2021-2025 (MT)
Figure 139. GCC Countries Cefotaxime Sodium API Value 2021-2025 ($ Millions)
Figure 140. REYOUNG Cefotaxime Sodium API Market Share (2018-2020)
Figure 141. CSPC Cefotaxime Sodium API Market Share (2018-2020)
Figure 142. Nectar Lifesciences Cefotaxime Sodium API Market Share (2018-2020)
Figure 143. Sandoz Cefotaxime Sodium API Market Share (2018-2020)
Figure 144. Kelun Cefotaxime Sodium API Market Share (2018-2020)
Figure 145. Medya Pharma Cefotaxime Sodium API Market Share (2018-2020)
Figure 146. United Laboratories Cefotaxime Sodium API Market Share (2018-2020)
Figure 147. NCPC Cefotaxime Sodium API Market Share (2018-2020)
Figure 148. Orchid Pharma Cefotaxime Sodium API Market Share (2018-2020)
Figure 149. Aurobindo Pharma Cefotaxime Sodium API Market Share (2018-2020)
Figure 150. Kopran Cefotaxime Sodium API Market Share (2018-2020)
Figure 151. Dawnrays Cefotaxime Sodium API Market Share (2018-2020)
Figure 152. ACS Dobfar Cefotaxime Sodium API Market Share (2018-2020)
Figure 153. Sterile India Cefotaxime Sodium API Market Share (2018-2020)
Figure 154. Covalent Cefotaxime Sodium API Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets